Expression of platelet parameters and platelet membrane glycoproteins in childhood Burkitt lymphoma. 2019

Renate Asare, and Clement Opoku-Okrah, and Kwabena Owusu Danquah, and Ohene Opare-Sem, and Otchere Addai-Mensah, and Daniel Gyamfi, and Francis Agyei Amponsah, and Edward Yaw Afriyie, and Richard Vikpebah Duneeh, and David Ntiamoah Ofosu, and Michael Frimpong
Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana. Electronic address: browny2gh@Yahoo.Com.

Platelet activation and functional changes in some haematological malignancies have been investigated with little or no known documentation on Burkitt lymphoma (BL). Abnormalities of platelets contribute to either haemorrhage or thrombotic episodes which are life-threatening in patients with BL. Thus, the study aimed at investigating the various platelet indices and platelet membrane glycoproteins in childhood Burkitt lymphoma. Platelet surface membrane glycoproteins (GPIIb/IIIa, P-selectin and GPIV using PAC 1, CD62p and CD36 monoclonal antibodies respectively) and platelet indices (Platelet Count [PLT], Plateletcrite [PCT], Mean Platelet Volume [MPV], Platelet Distribution Width [PDW] and Platelet Large Cell Ratio [P-LCR]) were determined in children with Burkitt lymphoma and healthy children (normal controls) based on flow cytometry and automated blood cell analysis techniques. PLT and PCT were higher in BL cases than in the normal controls with a significant difference in the PLT (P = 0.02). On the contrary, we observed a significant (p < 0.05) lower levels in the other platelet indices (MPV, PDW and P-LCR) in children with BL than the controls. With the exception of CD62 P, the other platelet membrane glycoproteins examined showed a decreased level of expression before and after the addition of an Adenosine -5- diphosphate (ADP) in cases of BL. In addition, PAC-1 was probably known to be associated with Burkitt Lymphoma (Odds Ratio [OR] 6.67, Relative Risk [RR] 3.13, 95% CI 1.06-9.21; p = 0.02). Finally, oral bleeding was observed to be the commonest bleeding episodes associated with childhood BL. Flow cytometry analysis and cell counting techniques of platelet assessment has described the expression of the platelet membrane glycoproteins and parameters in children with Burkitt lymphoma. Thus, children with Burkitt lymphoma tend to show normal to increased level of circulatory platelets but decreased platelet membrane glycoprotein expressions and platelet dysfunction.

UI MeSH Term Description Entries
D008297 Male Males
D010980 Platelet Membrane Glycoproteins Surface glycoproteins on platelets which have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. Many of these are receptors. PM-GP,Platelet Glycoprotein,Platelet Membrane Glycoprotein,PM-GPs,Platelet Glycoproteins,Glycoprotein, Platelet,Glycoprotein, Platelet Membrane,Glycoproteins, Platelet,Glycoproteins, Platelet Membrane,Membrane Glycoprotein, Platelet,Membrane Glycoproteins, Platelet,PM GP
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Renate Asare, and Clement Opoku-Okrah, and Kwabena Owusu Danquah, and Ohene Opare-Sem, and Otchere Addai-Mensah, and Daniel Gyamfi, and Francis Agyei Amponsah, and Edward Yaw Afriyie, and Richard Vikpebah Duneeh, and David Ntiamoah Ofosu, and Michael Frimpong
December 2015, Genetics and molecular research : GMR,
Renate Asare, and Clement Opoku-Okrah, and Kwabena Owusu Danquah, and Ohene Opare-Sem, and Otchere Addai-Mensah, and Daniel Gyamfi, and Francis Agyei Amponsah, and Edward Yaw Afriyie, and Richard Vikpebah Duneeh, and David Ntiamoah Ofosu, and Michael Frimpong
February 2008, Journal of pediatric hematology/oncology,
Renate Asare, and Clement Opoku-Okrah, and Kwabena Owusu Danquah, and Ohene Opare-Sem, and Otchere Addai-Mensah, and Daniel Gyamfi, and Francis Agyei Amponsah, and Edward Yaw Afriyie, and Richard Vikpebah Duneeh, and David Ntiamoah Ofosu, and Michael Frimpong
November 2014, Pediatric blood & cancer,
Renate Asare, and Clement Opoku-Okrah, and Kwabena Owusu Danquah, and Ohene Opare-Sem, and Otchere Addai-Mensah, and Daniel Gyamfi, and Francis Agyei Amponsah, and Edward Yaw Afriyie, and Richard Vikpebah Duneeh, and David Ntiamoah Ofosu, and Michael Frimpong
September 2023, Clinical journal of oncology nursing,
Renate Asare, and Clement Opoku-Okrah, and Kwabena Owusu Danquah, and Ohene Opare-Sem, and Otchere Addai-Mensah, and Daniel Gyamfi, and Francis Agyei Amponsah, and Edward Yaw Afriyie, and Richard Vikpebah Duneeh, and David Ntiamoah Ofosu, and Michael Frimpong
January 2003, Thrombosis research,
Renate Asare, and Clement Opoku-Okrah, and Kwabena Owusu Danquah, and Ohene Opare-Sem, and Otchere Addai-Mensah, and Daniel Gyamfi, and Francis Agyei Amponsah, and Edward Yaw Afriyie, and Richard Vikpebah Duneeh, and David Ntiamoah Ofosu, and Michael Frimpong
January 1994, Beitrage zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine,
Renate Asare, and Clement Opoku-Okrah, and Kwabena Owusu Danquah, and Ohene Opare-Sem, and Otchere Addai-Mensah, and Daniel Gyamfi, and Francis Agyei Amponsah, and Edward Yaw Afriyie, and Richard Vikpebah Duneeh, and David Ntiamoah Ofosu, and Michael Frimpong
July 1986, Sheng li ke xue jin zhan [Progress in physiology],
Renate Asare, and Clement Opoku-Okrah, and Kwabena Owusu Danquah, and Ohene Opare-Sem, and Otchere Addai-Mensah, and Daniel Gyamfi, and Francis Agyei Amponsah, and Edward Yaw Afriyie, and Richard Vikpebah Duneeh, and David Ntiamoah Ofosu, and Michael Frimpong
January 2002, Clinical laboratory,
Renate Asare, and Clement Opoku-Okrah, and Kwabena Owusu Danquah, and Ohene Opare-Sem, and Otchere Addai-Mensah, and Daniel Gyamfi, and Francis Agyei Amponsah, and Edward Yaw Afriyie, and Richard Vikpebah Duneeh, and David Ntiamoah Ofosu, and Michael Frimpong
August 2004, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
Renate Asare, and Clement Opoku-Okrah, and Kwabena Owusu Danquah, and Ohene Opare-Sem, and Otchere Addai-Mensah, and Daniel Gyamfi, and Francis Agyei Amponsah, and Edward Yaw Afriyie, and Richard Vikpebah Duneeh, and David Ntiamoah Ofosu, and Michael Frimpong
February 2002, Zhonghua yi xue za zhi,
Copied contents to your clipboard!